Paid Clinical Trials Oklahoma City

Discover 714 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 714

Rexlemestrocel-L & HAEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

Recruiting

PHASE3

Sponsor:

Mesoblast, Ltd.

Location:

Edmond OK, Kansas City KS, Greenwood CO, Birmingham ALshow 18 more

Code:

NCT06325566

Conditions

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rexlemestrocel-L + HA mixture

Saline

Pembrolizumab with GemcitabineTesting the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City OK, Fort Smith AR, Joplin MO, Great Bend KSshow 257 more

Code:

NCT04164082

Conditions

Bladder Flat Urothelial Carcinoma In Situ

Non-Muscle Invasive Bladder Urothelial Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Cystoscopy

Gemcitabine Hydrochloride

NX-1607A Study of NX-1607 in Adults With Advanced Malignancies

Recruiting

PHASE1

Sponsor:

Nurix Therapeutics, Inc.

Location:

Oklahoma City OK, Houston TX, Aurora CO, Chicago ILshow 5 more

Code:

NCT05107674

Conditions

Ovarian Cancer, Epithelial

Gastric Cancer

GastroEsophageal Junction (GEJ) Cancer

Head and Neck Squamous Cell Carcinoma

Metastatic or Unresectable Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NX-1607

Paclitaxel

Atrial FibrillationScreening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

Recruiting

Sponsor:

University of Oklahoma

Location:

Oklahoma City OK

Code:

NCT05784766

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

30-second ECG using the Kardia Mobile

routine care

EXPARELStudy to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Recruiting

PHASE1

Sponsor:

Pacira Pharmaceuticals, Inc

Location:

Oklahoma City OK, Houston TX, Durham NC

Code:

NCT06271265

Conditions

Postoperative Pain

Eligibility Criteria

Sex: All

Age: 0 - 6

Healthy Volunteers: Not accepted

Interventions

EXPAREL

bupivacaine

Thrombin Receptor AntagonistExcellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Recruiting

Sponsor:

North Texas Veterans Healthcare System

Location:

Oklahoma City OK, Dallas TX, Lubbock TX, Omaha NEshow 7 more

Code:

NCT02660866

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo + background APT + SMT

Vorapaxar 2.08 mg/d + background APT + SMT.

Rinatabart SesutecanRinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Recruiting

PHASE1

PHASE2

Sponsor:

Genmab

Location:

Oklahoma City OK, Fort Worth TX, Dallas TX, Abilene TXshow 26 more

Code:

NCT05579366

Conditions

Platinum-Resistant Ovarian Cancer

Platinum Sensitive Ovarian Cancer (PSOC)

High Grade Epithelial Ovarian Cancer

High Grade Serous Ovarian Cancer

Primary Peritoneal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rina-S

Carboplatin

Bevacizumab

Pembrolizumab

Observational StudyA Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Oklahoma City OK, Frisco TX, Lewisville TX, Fort Smith ARshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Combination ChemotherapyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

Recruiting

PHASE3

Sponsor:

University of Leicester

Location:

Oklahoma City OK, Fort Worth TX, Dallas TX, Amarillo TXshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide

N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa

Recruiting

PHASE3

Sponsor:

Johns Hopkins University

Location:

Oklahoma City OK, Dallas TX, Iowa City IA, Nashville TNshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo